SKIN
SkinHealth Systems Inc.
Overview
SkinHealth Systems Inc is a Consumer Defensive company operating in Household & Personal Products with a $85.9M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 5, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-0811 Q&A exchanges
- Q4 FY2025Earnings2026-03-1213 Q&A exchanges
- Q3 FY2025Earnings2025-11-0610 Q&A exchanges
- Q2 FY2025Earnings2025-08-0821 Q&A exchanges
- Q1 FY2025Earnings2025-05-1021 Q&A exchanges
- Q4 FY2024Earnings2025-03-1225 Q&A exchanges
- Q3 FY2024Earnings2024-11-1227 Q&A exchanges
- Q2 FY2024Earnings2024-08-0914 Q&A exchanges
- Q1 FY2024Earnings2024-05-098 Q&A exchanges
- Q4 FY2023Earnings2024-03-127 Q&A exchanges
- Q3 FY2023Earnings2023-11-13
- Q2 FY2023Earnings2023-08-0911 Q&A exchanges
- Q1 FY2023Earnings2023-05-1011 Q&A exchanges
- Q4 FY2022Earnings2023-02-2812 Q&A exchanges
- Q3 FY2022Earnings2022-11-0817 Q&A exchanges
- Q2 FY2022Earnings2022-08-0916 Q&A exchanges
- Q1 FY2022Earnings2022-05-1418 Q&A exchanges
- Q4 FY2021Earnings2022-02-2222 Q&A exchanges
- Q3 FY2021Earnings2021-11-0921 Q&A exchanges
- Q2 FY2021Earnings2021-08-1020 Q&A exchanges
- Q1 FY2021Earnings2021-05-13
History
Earnings history
- Q2 FY20262026-08-05EPS— vs $-0.03—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-05 | — | $-0.03 | — | — | — | — | EODHD |
Source: EODHD. SKIN reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks SKIN's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 9/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.23 | $3.45 | -6.4% | +1.4% | -0.6% |
| Q4 FY2026 | $3.07 | $3.56 | -13.8% | +5.9% | +8.2% |
| Q3 FY2026 | $3.21 | $3.69 | -13.0% | -0.9% | -1.6% |
| Q2 FY2026 | $3.39 | $3.59 | -5.6% | +4.1% | +2.8% |
| Q1 FY2025 | $3.33 | $3.60 | -7.5% | +7.5% | +7.4% |
| Q4 FY2025 | $3.64 | $3.61 | +0.8% | +5.5% | +6.9% |
| Q3 FY2025 | $3.65 | $3.71 | -1.6% | +5.1% | +7.5% |
| Q2 FY2025 | $3.46 | $3.71 | -6.7% | +5.6% | +5.5% |
| Q1 FY2024 | $3.43 | $3.58 | -4.3% | +6.0% | +3.1% |
| Q4 FY2024 | $3.45 | $3.66 | -5.7% | +1.2% | +1.8% |
Guidance change history
Sample- Q1 FY2026Lowered2026-04-15
- Q4 FY2026Lowered2026-13-15
- Q3 FY2026Lowered2026-10-15
- Q2 FY2026Lowered2026-07-15
- Q1 FY2025Lowered2025-04-15
- Q4 FY2025Maintained2025-13-15
- Q3 FY2025Maintained2025-10-15
- Q2 FY2025Lowered2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Pedro Bruno Ferreira MalhaCEO8 mono recorded callsCurrentSample
CEO since 2025 • 2/4 beats (50%) • guidance suspended Q3 FY2026
- Michael J U MonahanCFO1 yr 10 mo12 callsCurrentSample
CFO since 2024 • 6/8 beats (75%) • last guidance cut Q2 FY2026
- Sheri LewisCOO1 yr 4 mono recorded callsCurrentSample
COO since 2025 • 3/4 beats (75%) • last guidance cut Q2 FY2026
- Ronald MenezesChief Revenue Officer1 yr 4 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • guidance suspended Q1 FY2026
- Marla Malcolm BeckCEO1 mo1 callFormerSample
CEO since 2025 • 2/4 beats (50%) • guidance suspended Q2 FY2026
Peers
Other companies in Consumer Defensive
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SKIN.
$ curl https://api.spokenalpha.com/v1/companies/SKINFAQ
Frequently asked about SKIN
Where can I find SkinHealth Systems Inc.'s (SKIN) earnings call transcripts?
Spoken Alpha indexes SKIN's earnings call transcripts at https://spokenalpha.com/companies/SKIN. Each call links to attributed speakers and parsed analyst Q&A.
When was SkinHealth Systems Inc.'s most recent earnings call?
SkinHealth Systems Inc. (SKIN) held its most recent earnings call on 2026-05-08, covering fiscal Q1 2026.
What sector is SKIN in?
SkinHealth Systems Inc. (SKIN) operates in the Consumer Defensive sector (Household & Personal Products industry).